Condition

Neurofibroma clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Neurofibroma clinical trials that are recruiting, at sites in 2 countries (most in United States (2), France (1)). By phase: Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Neurofibroma clinical trials

StudyPhaseWhereStatusRegistered
Imlygic (T-VEC) injections for cutaneous neurofibromas in adults with NF1 Phase 1 Baltimore, Maryland Recruiting Aug 3, 2025
Assessing appearance concerns in Neurofibromatosis Type 1 patients — Bethesda, Maryland Recruiting Mar 18, 2025
Using cryotherapy to treat neurofibromas in patients with Neurofibromatosis Type 1 — Lyon Recruiting Jan 20, 2022

All recruiting trials (3)

Related topics

Neurofibroma, PlexiformNeurofibromatosisNeurofibromatosis Type 1NF1

Quick answers

How many Neurofibroma clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in United States (2 trials), France (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.